The deadliest US flu season in decades was expected to immunise CSL’s vaccine business from a growing anti-vaxxer sentiment. That’s not how it has played out.
The $20 billion group’s disgraceful year will come to a head this week as investors try to wrest back control from an underperforming board seeking a huge pay hike.
With Tabcorp shares soaring, investors were in no mood to deny yet another multimillion-dollar CEO options package for former AFL boss Gillon McLachlan.
Nothing highlights the US president’s trade delusions better than his victory over Australia’s beef ban. Record exports are now flowing in the opposite direction to what he intended.
Tracking app Life360 has shed its stalker image, and delivered a 1000 per cent return for local investors by leaning into its uncomfortable selling point: you can track your kids 24/7.
Tracking app Life360 has shed its stalker image, and delivered a 1000 per cent return for local investors by leaning into its uncomfortable selling point: you can track your kids 24/7.
CSL is battling the US president’s threat against big pharma and the vaccine scepticism of his health tsar, but that’s not why its shares plunged on Tuesday.
Coles, Woolies and IGA are losing a multibillion-dollar tobacco battle with a vicious new competitor, organised crime, and it is costing us all dearly.